Nongerminomatous Germ Cell Tumor — Trials

Nongerminomatous Germ Cell Tumor — Trials · CancerIndex

Clinical trials

Registered studies

62 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02689219	Brentuximab Vedotin in Relapsed/Refractory Germ Cell Tumors	terminated	Phase 2	18	Nabil AdraOTHER	1	Dec 10, 2019	clinicaltrials
NCT01808534	Palifosfamide in Treating Patients With Recurrent Germ Cell Tumors	terminated	Phase 2	5	Indiana UniversityOTHER	1	Jul 2, 2015	clinicaltrials
NCT01088763	Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia	terminated	Phase 1	129	National Cancer Institute (NCI)NIH	2	Nov 5, 2014	clinicaltrials

Data updated 22 days agoSource updated Dec 10, 2019source: clinicaltrials